Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4297 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Exelixis and Genentech form novel therapies alliance

The collaboration combines the intellectual property and biological capabilities of both companies to target proteins and genes that are involved in cell proliferation and differentiation. Under the collaboration,

Kosan drug shows activity in myeloma trials

Clinical data from a phase Ib combination trial, in which KOS-953 was administered with bortezomib (Millennium’s Velcade), also showed signs of anti-myeloma activity in bortezomib-naive and -refractory patients.

Cardio Vascu-Grow minimizes effects of stroke

Not only was the area affected by stroke minimized, the treated animals had significantly less neurological defects as assessed by several behavioral tests. In theory, this could indicate

Neurion wins grant to develop anxiety treatment

Phase I small business innovation research grant was awarded to Neurion by the National Institute of Mental Health (NIMH). Dr Paul Bennett, Neurion’s vice president of discovery, said: